PLEKHG5

Chr 1AR

pleckstrin homology and RhoGEF domain containing G5

Functions as a guanine exchange factor (GEF) for RAB26 and thus regulates autophagy of synaptic vesicles in axon terminal of motoneurons (By similarity). Involved in the control of neuronal cell differentiation (PubMed:11704860). Plays a role in angiogenesis through regulation of endothelial cells chemotaxis. Also affects the migration, adhesion, and matrix/bone degradation in macrophages and osteoclasts (PubMed:23777631)

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.562 OMIM phenotypes
Clinical SummaryPLEKHG5
🧬
Gene-Disease Validity (ClinGen)
neuromuscular disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
90 unique Pathogenic / Likely Pathogenic· 590 VUS of 1528 total submissions
Some data sources returned errors (1)

ncbi: SyntaxError: Bad control character in string literal in JSON at position 94 (line 1 column 95)

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.56LOEUF
pLI 0.000
Z-score 3.94
OE 0.38 (0.260.56)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.49Z-score
OE missense 0.84 (0.780.90)
552 obs / 659.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.38 (0.260.56)
00.351.4
Missense OE?0.84 (0.780.90)
00.61.4
Synonymous OE?1.01
01.21.6
LoF obs/exp: 18 / 47.2Missense obs/exp: 552 / 659.7Syn Z: -0.18

This gene — mechanism propensity

DN
0.6647th %ile
GOF
0.7126th %ile
LOF
0.3647th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

1528 submitted variants in ClinVar

Classification Summary

Pathogenic53
Likely Pathogenic37
VUS590
Likely Benign689
Benign89
Conflicting66
53
Pathogenic
37
Likely Pathogenic
590
VUS
689
Likely Benign
89
Benign
66
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
50
1
2
0
53
Likely Pathogenic
34
3
0
0
37
VUS
4
524
57
5
590
Likely Benign
1
19
305
364
689
Benign
2
12
70
5
89
Conflicting
66
Total915594343741,524

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

57 pathogenic / likely-pathogenic (of 68) ClinVar copy-number / structural variants overlap PLEKHG5 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PLEKHG5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →